{"nct_id":"NCT05458011","title":"A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2022-09-30","start_date_type":"ACTUAL","primary_completion_date":"2024-01-31","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}